Secondary hyperaldosteronism and hypertension
Introduction: Arterial hypertension is a major cardiovascular risk factor affecting about 10-40% of the adult population. Secondary endocrine hypertension most often results from excessive aldosterone secretion. Complications related to excessive aldosterone secretion include atrial fibrillation, my...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN SR |
Publicado: |
Medicinski fakultet Priština, Društvo lekara Kosova i Metohije Srpskog lekarskog društva
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/372f0fd83cdf4f0cb82b289a70d9113a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:372f0fd83cdf4f0cb82b289a70d9113a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:372f0fd83cdf4f0cb82b289a70d9113a2021-12-05T21:29:52ZSecondary hyperaldosteronism and hypertension0350-87732560-331010.5937/pramed2102051Mhttps://doaj.org/article/372f0fd83cdf4f0cb82b289a70d9113a2021-01-01T00:00:00Zhttps://scindeks-clanci.ceon.rs/data/pdf/0350-8773/2021/0350-87732101051M.pdfhttps://doaj.org/toc/0350-8773https://doaj.org/toc/2560-3310Introduction: Arterial hypertension is a major cardiovascular risk factor affecting about 10-40% of the adult population. Secondary endocrine hypertension most often results from excessive aldosterone secretion. Complications related to excessive aldosterone secretion include atrial fibrillation, myocardial infarction, myocardial fibrosis, left ventricular hypertrophy, stroke, and increased cardiovascular mortality. Case report: This report presents a hypotensive woman with hypertensive reactions, newly diagnosed unilateral hyperplasia of the left adrenal gland and secondary hyperaldosteronism. Due to good blood pressure and normalized electrolyte status as a result of antihypertensive drug therapy and absence of damage to target organs, surgical treatment of unilateral adrenal hyperplasia was postponed. Conclusion: In case of midlife and late-life hypertension, it is necessary to consider a cause in the patient's endocrine system. AUTHORS SUMMARY SRPSKI 2021; 50 (1,2) 51-54Mijalković MilošPajović SlavicaJovanović AleksandarŠipić MajaMedicinski fakultet Priština, Društvo lekara Kosova i Metohije Srpskog lekarskog društvaarticlehyperaldosteronismunilateral adrenal hyperplasiahypertensionMedicineRENSRPraxis Medica, Vol 50, Iss 1-2, Pp 51-54 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN SR |
topic |
hyperaldosteronism unilateral adrenal hyperplasia hypertension Medicine R |
spellingShingle |
hyperaldosteronism unilateral adrenal hyperplasia hypertension Medicine R Mijalković Miloš Pajović Slavica Jovanović Aleksandar Šipić Maja Secondary hyperaldosteronism and hypertension |
description |
Introduction: Arterial hypertension is a major cardiovascular risk factor affecting about 10-40% of the adult population. Secondary endocrine hypertension most often results from excessive aldosterone secretion. Complications related to excessive aldosterone secretion include atrial fibrillation, myocardial infarction, myocardial fibrosis, left ventricular hypertrophy, stroke, and increased cardiovascular mortality. Case report: This report presents a hypotensive woman with hypertensive reactions, newly diagnosed unilateral hyperplasia of the left adrenal gland and secondary hyperaldosteronism. Due to good blood pressure and normalized electrolyte status as a result of antihypertensive drug therapy and absence of damage to target organs, surgical treatment of unilateral adrenal hyperplasia was postponed. Conclusion: In case of midlife and late-life hypertension, it is necessary to consider a cause in the patient's endocrine system. AUTHORS SUMMARY SRPSKI 2021; 50 (1,2) 51-54 |
format |
article |
author |
Mijalković Miloš Pajović Slavica Jovanović Aleksandar Šipić Maja |
author_facet |
Mijalković Miloš Pajović Slavica Jovanović Aleksandar Šipić Maja |
author_sort |
Mijalković Miloš |
title |
Secondary hyperaldosteronism and hypertension |
title_short |
Secondary hyperaldosteronism and hypertension |
title_full |
Secondary hyperaldosteronism and hypertension |
title_fullStr |
Secondary hyperaldosteronism and hypertension |
title_full_unstemmed |
Secondary hyperaldosteronism and hypertension |
title_sort |
secondary hyperaldosteronism and hypertension |
publisher |
Medicinski fakultet Priština, Društvo lekara Kosova i Metohije Srpskog lekarskog društva |
publishDate |
2021 |
url |
https://doaj.org/article/372f0fd83cdf4f0cb82b289a70d9113a |
work_keys_str_mv |
AT mijalkovicmilos secondaryhyperaldosteronismandhypertension AT pajovicslavica secondaryhyperaldosteronismandhypertension AT jovanovicaleksandar secondaryhyperaldosteronismandhypertension AT sipicmaja secondaryhyperaldosteronismandhypertension |
_version_ |
1718370936240996352 |